PREPARE Challenge: Advance Early Prediction for Alzheimer's and Related Dementia
NASA Tournament Lab (via HeroX)
This opportunity closed July 1, 2025. 2 similar opportunities are open right now.
Similar opportunities open now
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)OpenNational Institutes of HealthCloses Nov 2026
- DoW Alzheimer’s Transforming Diagnosis AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 38 days
About this archived opportunity
Overview Problem StatementAlzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) impact over 6 million Americans, causing progressive cognitive, functional, and behavioral impairments. Early detection is crucial, especially with emerging treatment options, but current clinical tools are not sensitive enough for early prediction. The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), is running the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer's and Related Dementias EUREKA Challenge) to advance solutions for accurate, innovative, and representative early prediction of AD/ADRD. To achieve this goal, the challenge will feature three phases that successively build on each other.Anticipated Dates: Phase IChallenge launch - September 1, 2023Executive summary drafts due - January 17, 2024Submissions due - January 31, 2024Finalists notified - March 18, 2024Finalists provide data access for verification - June 1, 2024Winners selected and notified after verification - June 17, 2024 through August 30, 2024Winners publicly announced - September 2024Phase IIChallenge launch - October 22, 2024Model Submissions due - December 19, 2024Report Submissions due - January 22, 2025Verified winners notified - March 31, 2025Winners publicly announced - April 16, 2025Tentative Phase III DatesSubmissions due - July 1, 2025Winners publicly announced - November 2025Interested in competing? Click Learn More for more information and to register! Learn More
Historical details
- Status
- Closed
- Deadline
- July 1, 2025
- First captured
- January 9, 2026
- Award
- $650,000
- Publisher reference
- https://www.herox.com/PREPARE
Free. One email, sent if this program reopens or a close match to it opens. We watch for 12 months, then stop. No list.
Related opportunities
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)National Institutes of HealthCloses Nov 2026
- DoW Alzheimer’s Transforming Diagnosis AwardDefense Health Agency Contracting Activity - DHACACloses in 38 days